In a second study, the same group hypothesized that variants in the estrogen receptor (ESR1), vitamin D receptor (VDR), and/or collagen 1α1 (COL1A1) gene could be osteosarcoma risk factors. The gene discussed is ESR1; the disease is osteosarcoma.